医药行业分析
- (2020-01-15)
- (2020-01-15)
- (2020-01-15)
邱录贵教授:利妥昔单抗是淋巴瘤免疫化疗的“基石”药物,为惰性B细胞淋巴瘤带来显著生存获益丨2020年白血病·淋巴瘤高峰论坛
(2020-01-15)- (2020-01-15)
- (2020-01-15)
- (2020-01-15)
- (2020-01-15)
- (2020-01-15)
- (2020-01-15)
- (2020-01-15)
- (2020-01-15)
- (2020-01-15)
- (2020-01-15)
- (2020-01-15)
- (2020-01-15)
- (2020-01-15)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-14)
- (2020-01-13)
- (2020-01-13)
- (2020-01-13)
- (2020-01-13)
- (2020-01-13)
- (2020-01-13)
- (2020-01-13)
- (2020-01-13)
- (2020-01-10)
- (2020-01-10)
- (2020-01-10)
- (2020-01-10)
- (2020-01-10)
- (2020-01-10)
- (2020-01-10)
- (2020-01-10)
- (2020-01-09)
- (2020-01-09)